Literature DB >> 27234321

Metastatic melanoma: Pathologic characterization, current treatment, and complications of therapy.

Mark R Wick1, Alejandro A Gru2.   

Abstract

Metastatic melanoma (MM) has the potential to involve virtually any anatomical site, and it also has a wide spectrum of histological appearances. General clinicopathologic data pertaining to MM are presented in this review, together with a discussion of its differential diagnosis and therapy. "Biological" agents used in the treatment of melanoma are considered, along with the pathological features of the complications that they may cause.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Adjunctive morphological studies; Biological therapy; Complications of treatment; Metastatic melanoma

Mesh：

Year:  2016        PMID： 27234321     DOI： 10.1053/j.semdp.2016.04.005

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN： 0740-2570            Impact factor:   3.464


  5 in total

1.  [Construction and verification of anti-MM scFv-tP fusion protein expression vector].

Authors:  Hao Wang; Yi-Fei Yang; Wei Wang; Bing Guan; Meng Xun; Hai Zhang; Zi-Ling Wang; Yong Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

2.  Expression of PIWIL3 in primary and metastatic melanoma.

Authors:  Thilo Gambichler; Christina Kohsik; Ann-Kathrin Höh; Kerstin Lang; Heiko U Käfferlein; Thomas Brüning; Eggert Stockfleth; Markus Stücker; Max Dreißigacker; Michael Sand
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-17       Impact factor: 4.553

3.  Occult Metastatic Melanoma Presenting as an Acute Coronary Syndrome.

Authors:  Tiago R Velho; Nádia Junqueira; André Sena; Hugo Ferreira; Catarina Carvalheiro; Nuno Guerra; Javier Gallego; Ângelo Nobre
Journal:  Braz J Cardiovasc Surg       Date:  2017 May-Jun

4.  Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.

Authors:  Jiaojiao Hao; Wenhua Fan; Yizhuo Li; Ranran Tang; Chunfang Tian; Qian Yang; Tianhua Zhu; Chaoliang Diao; Sheng Hu; Manyu Chen; Ping Guo; Qian Long; Changlin Zhang; Ge Qin; Wendan Yu; Miao Chen; Liren Li; Lijun Qin; Jingshu Wang; Xiuping Zhang; Yandong Ren; Penghui Zhou; Lijuan Zou; Kui Jiang; Wei Guo; Wuguo Deng
Journal:  J Exp Clin Cancer Res       Date:  2019-02-04

5.  Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer.

Authors:  Mark Kriegsmann; Katharina Kriegsmann; Alexander Harms; Rémi Longuespée; Christiane Zgorzelski; Jonas Leichsenring; Thomas Muley; Hauke Winter; Daniel Kazdal; Benjamin Goeppert; Arne Warth
Journal:  Diagn Pathol       Date:  2018-09-11       Impact factor: 2.644
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.